Thromboprophylaxis with enoxaparin is associated with a lower death rate in patients hospitalized with SARS-CoV-2 infection. A cohort study

BACKGROUND: Severe Acute Respiratory Syndrome CoronaVirus 2 (SARS-CoV-2) infection is associated with hypercoagulability caused by direct invasion of endothelial cells and\or proinflammatory cytokine release. Thromboprophylaxis with enoxaparin is recommended by current guidelines, but evidence is st...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Τόπος έκδοσης:EClinicalMedicine
Κύριοι συγγραφείς: Albani, Filippo, Sepe, Lilia, Fusina, Federica, Prezioso, Chiara, Baronio, Manuela, Caminiti, Federica, Di Maio, Antonella, Faggian, Barbara, Franceschetti, Maria Elena, Massari, Marco, Salvaggio, Marcello, Natalini, Giuseppe
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: Elsevier 2020
Θέματα:
Research paper
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7534836/
https://ncbi.nlm.nih.gov/pubmed/33043287
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.eclinm.2020.100562
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια